Clarithromycin
Back to searchMolecule Structure
Scientific Name
Clarithromycin
Description of the Drug
Clarithromycin is a macrolide antibiotic used for the treatment of a wide variety of bacterial infections such as acute otitis, pharyngitis, tonsillitis, respiratory tract infections, uncomplicated skin infections, and helicobacter pylori infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01211
http://www.drugbank.ca/drugs/DB01211
Brand Name(s)
Biaxin, Biaxin xl, Biaxin Xl Pac, Clarie xl, Clarithromycin, Clarithromycin Extended Release, Clarosip, Febzin xl, Klaricid, Klaricid 500, Klaricid adult, Klaricid i.v., Klaricid paed, Klaricid xl, Mycifor xl, Xetinin xl, Zeclar
Company Owner(s)
Nostrum Laboratories Inc, Abbvie Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Lupin Ltd, Sun Pharmaceutical Industries Ltd, Mayne Pharma Llc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Rising Pharma Holdings Inc, Sandoz Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL38125 | ||
| PharmGKB | PA449028 | ||
| Human Metabolome Database | HMDB0015342 | ||
| DrugBank | DB01211 | ||
| PubChem: Thomson Pharma | 14913515 | 14937909 | |
| PubChem | 84029 | ||
| Mcule | MCULE-7168853332 | ||
| LINCS | LSM-5606 | ||
| Nikkaji | J134.033F | ||
| PDBe | CTY | ||
| BindingDB | 50404044 | ||
| EPA CompTox Dashboard | DTXSID3022829 | ||
| LipidMaps | LMPK04000014 | ||
| DrugCentral | 668 | ||
| Brenda | 229298 | 22099 | 229297 |
| ChemicalBook | CB2225614 | ||
| Guide to Pharmacology | 10903 | ||
| GSRS | 31dbbf15-4c12-4ff3-a404-068c5772ddc5 | ||
| rxnorm | CLARITHROMYCIN | BIAXIN | |
| PubChem: Drugs of the Future | 12013874 | ||
| KEGG Ligand | C06912 | ||
| ChEBI | 3732 | ||
| NIH Clinical Collection | SAM001246748 | ||
| ZINC | ZINC000085534098 |
